Q1 2021 Holdings
Filed 2021-05-17 | 31 holdings | $630.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Atea Pharmaceuticals, Inc.(AVIR) | COM | 04683R106 | $346.8M | 5,615,659 | 55.0% |
| Arcutis Biotherapeutics, Inc.(ARQT) | COM | 03969K108 | $115.1M | 3,979,292 | 18.3% |
| Annexon Inc(ANNX) | COM | 03589W102 | $90.2M | 3,241,628 | 14.3% |
| C4 Therapeutics, Inc.(CCCC) | COM STK | 12529R107 | $60.7M | 1,642,209 | 9.6% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $16.4M | 1,071,428 | 2.6% |
| Springworks Therapeutics Inc | COM | 85205L107 | $429.0K | 5,831,307 | 0.1% |
| Dynavax Technologies Corp(DVAX) | COM | 268158201 | $107.1K | 10,895,773 | 0.0% |
| Pharvaris N.V.(PHVS) | COM | N69605108 | $89.0K | 3,180,601 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $78.8K | 3,080,237 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $59.8K | 3,695,667 | 0.0% |
| Solid Biosciences Inc | COM | 83422E105 | $43.9K | 7,929,918 | 0.0% |
| Syros Pharmaceuticals, Inc. | COM | 87184Q107 | $43.3K | 5,785,036 | 0.0% |
| Nurix Therapeutics, Inc.(NRIX) | COM | 67080M103 | $39.9K | 1,284,314 | 0.0% |
| Constellation Pharmaceuticals, Inc.(CNST) | COM | 210373106 | $32.7K | 1,400,000 | 0.0% |
| Aptinyx Inc | COM | 03836N103 | $26.7K | 8,891,758 | 0.0% |
| Savara Inc(SVRA) | COM | 805111101 | $24.2K | 11,622,598 | 0.0% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM | 56854Q200 | $22.2K | 1,431,058 | 0.0% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | COM | 00773J103 | $21.4K | 2,700,000 | 0.0% |
| Kymera Therapeutics Inc.(KYMR) | COM | 501575104 | $18.6K | 479,605 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $18.2K | 2,119,540 | 0.0% |
| Bluebird BIO, Inc. | COM | 09609G100 | $16.2K | 538,179 | 0.0% |
| Arya Sciences Acquisition Corp III | COM CL A | G3166W106 | $13.8K | 1,000,000 | 0.0% |
| Therapeutics Acquisition Corp | COM CL A | 88339T103 | $10.5K | 1,000,000 | 0.0% |
| Research Alliance Corp II | COM CL A | 760873109 | $10.3K | 1,000,000 | 0.0% |
| Arya Sciences Acquisition Corp IV | CL A | G31659108 | $7.3K | 700,000 | 0.0% |
| Bctg Acquisition Corp | COM | 05492W103 | $5.6K | 500,000 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $5.2K | 487,500 | 0.0% |
| Omega Alpha Spac | CL A | G6749V107 | $4.0K | 400,000 | 0.0% |
| Frazier Lifesciences Acquisition Corp | UNIT 12/09/2025 | G3710A121 | $3.0K | 300,000 | 0.0% |
| Jiya Acquisition Corp | COM CL A | 47760M102 | $3.0K | 300,000 | 0.0% |
| Helix Acquisition Corp | COM CL A | G4444C102 | $2.6K | 250,000 | 0.0% |